Jupiter Topco’s Immix Biopharma IMMX Stock Holding History

Jupiter Topco’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$101M	Buy	+9,783,192	New	+$90.8M	0.04%	309

Other funds holding IMMX

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Jupiter Topco's IMMX Position: Q2 2026 in Review

Jupiter Topco opened a new position in Immix Biopharma (IMMX) in Q2 2026: 9,783,192 shares worth $101M. The stake represents 0.04% of the portfolio and ranks #309 among its holdings.

101 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

Jupiter Topco held 9,783,192 shares of Immix Biopharma worth $101M as of Q2 2026.
Immix Biopharma was a new Jupiter Topco position in Q2 2026.
Immix Biopharma made up 0.04% of Jupiter Topco's portfolio in Q2 2026, its #309 holding.
101 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.